APA (7th ed.) Citation

RJ, V., JS, d. G., BO, F., MN, H., AM, M., & KPM, S. (2024). Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 42(31), 3713. https://doi.org/10.1200/JCO.24.00191

Chicago Style (17th ed.) Citation

RJ, Verheijden, de Groot JS, Fabriek BO, Hew MN, May AM, and Suijkerbuijk KPM. "Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 42, no. 31 (2024): 3713. https://doi.org/10.1200/JCO.24.00191.

MLA (9th ed.) Citation

RJ, Verheijden, et al. "Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 42, no. 31, 2024, p. 3713, https://doi.org/10.1200/JCO.24.00191.